Article info
Original Article
Recurrence risk after sentinel lymph node biopsy in patients with early cervical cancer: Follow-up results after 3 years of a prospective study (SENTICOL)
- Correspondence to Patrice Mathevet, UNIL, Université de Lausanne, Lausanne 1015, Switzerland; patrice.mathevet{at}chuv.ch
Citation
Recurrence risk after sentinel lymph node biopsy in patients with early cervical cancer: Follow-up results after 3 years of a prospective study (SENTICOL)
Publication history
- Received August 1, 2018
- Revision received November 22, 2018
- Accepted November 29, 2018
- First published January 4, 2019.
Article Versions
- You are currently viewing a Previous version of this article (4 January 2019).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.